Eli Lilly and Company

Anne Marie Nunes

Hamideh Zarrinmayeh

Paul Leslie Ornstein

Dennis Michael Zimmerman

Philip Arthur Hipskind

Thomas Charles Britton

Karen Lynn Lobb

Robert F Bruns, Jr

Edward C R Smith

James Arthur Nixon

Buddy Eugene Cantrell

James Jeffry Howbert

This invention provides a series of substituted benzimidazoles which are useful in treating or preventing a condition associated with an excess of neuropeptide Y. This invention also provides methods employing these substituted benzimidazoles as well as pharmaceutical formulations with comprise as an active ingredient one or more of these compounds.

Benzimidzolyl neuropeptide Y receptor antagonists

This invention provides a series of substituted 1H-naphth�2,3-d!imidazoles which are useful in treating a condition associated with an excess of neuropeptide Y. This invention also provides methods employing these substituted 1H-naphth�2,3-d!imidazoles as well as pharmaceutical formulations with comprise as an active ingredient one or more of these compounds.

Naphthimidazolyl neuropeptide Y receptor antagonists

Growing community of inventors

Andover, MA, United States of America

Anne Marie Nunes